CN111671793B - Production process of sterilized paper towel - Google Patents

Production process of sterilized paper towel Download PDF

Info

Publication number
CN111671793B
CN111671793B CN202010446617.1A CN202010446617A CN111671793B CN 111671793 B CN111671793 B CN 111671793B CN 202010446617 A CN202010446617 A CN 202010446617A CN 111671793 B CN111671793 B CN 111671793B
Authority
CN
China
Prior art keywords
disinfectant
paper towel
sterilized
production process
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010446617.1A
Other languages
Chinese (zh)
Other versions
CN111671793A (en
Inventor
乔文洲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010446617.1A priority Critical patent/CN111671793B/en
Publication of CN111671793A publication Critical patent/CN111671793A/en
Application granted granted Critical
Publication of CN111671793B publication Critical patent/CN111671793B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02—Amines; Quaternary ammonium compounds
    • A01N33/12—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
    • A01N47/42—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
    • A01N47/44—Guanidine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08—Magnoliopsida [dicotyledons]
    • A01N65/24—Lauraceae [Laurel family], e.g. laurel, avocado, sassafras, cinnamon or camphor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The invention discloses a disinfectant, which comprises the following components in parts by weight: 2-5 parts of hexamethylguanidine hydrochloride, 0.5-2 parts of benzethonium chloride and 1-3 parts of cassia bark extract. The polyhexamethylene guanidine hydrochloride, the benzethonium chloride and the cinnamon extract in a specific ratio are added into the disinfectant, so that the disinfectant has a good bactericidal effect on gram-negative bacteria and gram-positive bacteria, and particularly has a good bacteriostatic bactericidal effect on food-borne pathogenic bacteria (staphylococcus aureus, escherichia coli and the like). The invention also discloses a production process of the sterilized paper towel and the sterilized paper towel prepared by the production process, wherein the sterilized paper towel adsorbs the disinfectant, and the prepared dry paper product has a certain sterilization effect even if the retention time is short.

Description

Production process of sterilized paper towel
Technical Field
The invention relates to a sterilized paper towel, in particular to a production process of a sterilized dry paper towel.
Background
The use of paper towels with a sterilising function as napkins in restaurants or other locations reduces the risk of oral transmission of bacteria to some extent. The paper towels with the sterilization and disinfection effects in the market at present are generally wet paper towels, the dry paper towels with the sterilization and disinfection effects are few in variety, and some dry paper towels only have the sterilization and disinfection effects and are actually little in effect.
Disclosure of Invention
The invention aims to overcome the defects in the prior art and provide a production process of a sterilized dry tissue.
In order to achieve the purpose, the invention adopts the technical scheme that: the disinfectant comprises the following components in parts by weight: 2-5 parts of hexamethylguanidine hydrochloride, 0.5-2 parts of benzethonium chloride and 1-3 parts of cassia bark extract.
The hexamethylguanidine hydrochloride can make the polymer become electropositive and can be easily adsorbed by various negatively charged bacteria and viruses, thereby inhibiting the division function of the bacteria and the viruses and leading the bacteria and the viruses to lose the reproductive capacity, and a film formed by the polymer blocks a breathing channel of microorganisms to lead the microorganisms to be rapidly suffocated and die. Benzethonium chloride has good bactericidal effect on staphylococcus aureus and escherichia coli. The cinnamon extract has a certain inhibiting effect on staphylococcus aureus and bacillus subtilis, and is an alcohol extract of cinnamon, wherein the content of the cinnamon extract in the alcohol extract of cinnamon is 10-12%. The polyhexamethylene guanidine hydrochloride, the benzethonium chloride and the cinnamon extract are added into the disinfectant, so that the disinfectant has a good bactericidal effect on gram-negative bacteria and gram-positive bacteria, and particularly has a good bacteriostatic bactericidal effect on food-borne pathogenic bacteria (staphylococcus aureus, escherichia coli and the like) when the disinfectant is used in a matching manner according to the proportion. The disinfectant still has a certain bactericidal effect on dry paper products adsorbed with the disinfectant.
As a preferred embodiment of the disinfectant, the disinfectant further comprises 3-6 parts of sodium diacetate. The addition of sodium diacetate can increase the sterilization and disinfection effects of the disinfectant.
As a preferred embodiment of the disinfectant, the disinfectant comprises the following components in percentage by weight: 2-5% of hexamethylguanidine hydrochloride, 0.5-2% of benzethonium chloride, 1-3% of cinnamon bark extract, 3-6% of sodium diacetate and the balance of ethanol.
As a preferred embodiment of the disinfectant, the disinfectant comprises the following components in percentage by weight: 3.5 percent of hexamethylguanidine hydrochloride, 1 percent of benzethonium chloride, 2 percent of cassia bark extract, 4 percent of sodium diacetate and the balance of ethanol. The disinfectant prepared by the above proportion has the best sterilization effect.
The invention also aims to provide the application of the disinfectant in the preparation of paper towels.
The invention also aims to provide a production process of the sterilized paper towel, which comprises the following steps:
(1) attaching a disinfectant to the surface of the single-layer tissue;
(2) attaching at least one layer of paper towel to the surface of the paper towel which is not attached with the disinfectant, drying, embossing, cutting paper, and packaging to obtain the disinfected paper towel;
the disinfectant is the disinfectant;
the dosage of the disinfectant is 1-5 g/m2。
The disinfectant is applied to the surface of one layer of the paper towel, and the prepared dry paper towel has certain sterilization and disinfection effects even if the retention time is short. The drying, embossing, cutting and packaging can adopt the production process commonly used in the field.
As a preferred embodiment of the production process of the sterilized paper towel of the present invention, the process further comprises, between the step (1) and the step (2): and adhering an adhesive to the surface of the toilet paper without the disinfectant.
As a preferred embodiment of the production process of the sterilized paper towel of the present invention, in the step (2), a layer of paper towel is attached to the surface of the paper towel to which the disinfectant is not attached. When the disinfection tissue is of a two-layer structure, the disinfectant is attached to one layer, so that the disinfection tissue has a good disinfection effect and is low in cost.
The invention also aims to provide the sterilized paper towel produced by the production process of the sterilized paper towel.
The invention has the beneficial effects that: the invention provides a disinfectant, which is added with hexamethylguanidine hydrochloride, benzethonium chloride and cinnamon extract in a specific ratio, and has a good bactericidal effect on gram-negative bacteria and gram-positive bacteria, particularly food-borne bacteria (staphylococcus aureus, escherichia coli and the like). The invention also provides a production process of the disinfectant paper towel and the disinfectant paper towel prepared by the production process, wherein the disinfectant is adsorbed on the disinfectant paper towel, and the prepared dry paper product has a certain sterilization effect even if the retention time is short.
Detailed Description
To better illustrate the objects, aspects and advantages of the present invention, the present invention will be further described with reference to specific examples.
Examples 1 to 5 and comparative examples 1 to 3
The components of the disinfectants described in examples 1-5 and comparative examples 1-3 are shown in Table 1.
TABLE 1
Figure BDA0002504555410000031
The disinfectant disclosed in the embodiments 1-5 and the comparative examples 1-3 is applied to the preparation of the paper towel, and the preparation process comprises the following steps:
(1) spraying a disinfectant on the surface of the single-layer tissue to attach the disinfectant to the surface of the tissue; adhering an adhesive to the surface of the toilet paper without the disinfectant;
(2) attaching the other layer of paper towel to the surface of the paper towel which is not attached with the disinfectant, drying, embossing, cutting paper, and packaging to obtain the disinfected paper towel; the disinfectant is the disinfectant described in the embodiment 1-5 and the comparative example 1-3; the dosage of the disinfectant is 2g/m2。
The disinfectant tissues prepared by the disinfectants in the embodiments 1-5 and the comparative examples 1-3 are entrusted to a third party organization for a sterilization effect test, and the test method specifically comprises the following steps:
1. preparing bacterial liquid: subculturing the strain for 2-3 times, inoculating on agar solid culture medium, culturing at 37 deg.C for 24 hr, performing amplification culture on single colony in liquid LB culture medium, and controlling the concentration at (1.0-5.0) × 10 by spectrophotometer9CFU/mL, the disinfectant paper towels prepared by the disinfectants of the examples 1-5 and the comparative examples 1-3 are respectively prepared into strips (1mm multiplied by 4mm) with 2 blocks, and 64 strips are taken in total.
2. Determination of the growth number of microorganisms by OD value: pouring the bacterial liquid into a cuvette, selecting a 600nm wavelength spectrophotometer to adjust a zero point as a blank control, measuring the OD value of the bacterial liquid after 0 hour, diluting the bacterial suspension with PBS and measuring to ensure that the OD value is within 0.10-0.65, and multiplying the OD value measured after dilution by the dilution multiple to obtain the actual OD value.
3. And (3) antibacterial experiment: 8 100mL triangular flasks containing 50mL of PBS buffer were prepared. 3mL of staphylococcus aureus liquid and 3mL of escherichia coli liquid are respectively added into 8 triangular flasks, then 8 samples are respectively added into the two types of liquid, 4 samples are added into each type of liquid, and one bottle of each type of liquid is selected as a blank control. Samples were taken from the culture at 180r/min for t hours at "0" contact time and 30 ℃ respectively. Plate counts were performed after dilution at different multiples and plate counts of appropriate dilution concentrations between 30-300 were selected as the final results of the experiment.
4. Plate counting method for determining the number of microorganisms: respectively taking bacterial liquid of 8 samples cultured for 18h and a control, selecting 3 appropriate dilutions, respectively preparing 10-fold progressive dilution, and simultaneously transferring 1mL of the dilutions into a sterilized flat dish by using a pipette for sucking the dilutions, wherein 3 dilutions are made in parallel. About 15mL of nutrient agar medium cooled to 46 ℃ is poured into the plate, the plate is rotated, and the mixture is mixed uniformly. Meanwhile, the nutrient agar medium was poured into a sterile plate to which 1mL of the diluent (without sample) was added as a blank. And after the agar is solidified, turning over the plate, culturing for 18h in an incubator at 36 +/-1 ℃, taking out the plate, calculating the number of bacterial colonies in the plate, and multiplying the number by the dilution times to obtain the total number of bacterial colonies contained in each gram (per milliliter) of sample shown in the table 2, thereby obtaining the bacteriostasis rate of the disinfection paper towel.
5. The formula for calculating the bacteriostasis rate is as follows: x is a-B/a × 100%.
In the formula: x-bacteriostatic rate,%;
a-average number of colonies in control sample;
b-average colony count of test piece,
6. Evaluation criteria: the bacteriostasis rate is more than or equal to 50-90 percent, and the product has bacteriostasis. The bacteriostasis rate is more than or equal to 90 percent, and the product has stronger bacteriostasis.
TABLE 2
Group of Antibacterial rate of Escherichia coli Golden yellow grape ball bacteriostasis rate
Example 1 82.20％ 80.33％
Example 2 75.69％ 69.56％
Example 3 70.50％ 76.21％
Example 4 78.15％ 68.25％
Example 5 56.25％ 60.31％
Comparative example 1 32.65％ 42.26％
Comparative example 2 40.69％ 53.05％
Comparative example 3 45.24％ 51.64％
As can be seen from the table 2, the disinfectant paper towel prepared by the disinfectant disclosed by the invention has a certain bacteriostatic effect, particularly the bacteriostatic effect of the disinfectant in the embodiment 1 is optimal, and the bacteriostatic effect of the disinfectant in the comparative examples 1-3 which lack one of the components is obviously reduced.
Finally, it should be noted that the above embodiments are only used for illustrating the technical solutions of the present invention and not for limiting the protection scope of the present invention, and although the present invention is described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions can be made on the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention.

Claims (4)

1. The application of the disinfectant in preparing the disinfectant paper towel is characterized in that the disinfectant is prepared from the following components in percentage by weight: 3.5% of hexamethylguanidine hydrochloride, 1% of benzethonium chloride, 2% of cassia bark extract, 4% of sodium diacetate and the balance of ethanol; the sterilized paper towel is a sterilized dry paper towel.
2. The production process of the sterilized paper towel is characterized by comprising the following steps:
(1) attaching a disinfectant to the surface of the single-layer tissue;
(2) attaching at least one layer of paper towel to the surface of the paper towel which is not attached with the disinfectant, drying, embossing, cutting paper, and packaging to obtain the disinfected paper towel;
the disinfectant is the disinfectant of claim 1;
the dosage of the disinfectant is 1-5 g/m2。
3. The process for producing a sterilized paper towel according to claim 2, wherein in the step (2), a layer of paper towel is attached to the surface of the paper towel to which the sterilizing agent is not attached.
4. A sterilized paper towel produced by the production process of the sterilized paper towel of any one of claims 2 to 3.
CN202010446617.1A 2020-05-22 2020-05-22 Production process of sterilized paper towel Active CN111671793B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010446617.1A CN111671793B (en) 2020-05-22 2020-05-22 Production process of sterilized paper towel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010446617.1A CN111671793B (en) 2020-05-22 2020-05-22 Production process of sterilized paper towel

Publications (2)

Publication Number Publication Date
CN111671793A CN111671793A (en) 2020-09-18
CN111671793B true CN111671793B (en) 2022-05-10

Family

ID=72452850

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010446617.1A Active CN111671793B (en) 2020-05-22 2020-05-22 Production process of sterilized paper towel

Country Status (1)

Country Link
CN (1) CN111671793B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100230978B1 (en) * 1997-03-07 1999-11-15 남창우 A polyhexamethyleneguanidine salts having a branched alkylgroup, method for preparing same and uses as antimicrobial agents
CN102379449B (en) * 2011-07-26 2014-04-09 江苏大学 Ethanolic extract of cinnamons and application thereof in preparing food preservatives
CN103520029B (en) * 2013-09-22 2016-03-02 天津市中科健新材料技术有限公司 The dry towel manufacture method of a kind of sterilization
CN103993505B (en) * 2014-04-29 2016-06-08 金红叶纸业集团有限公司 Bactericidal composition and anti-bacteria paper for paper products
CN108309838A (en) * 2018-05-04 2018-07-24 山东顺皓聚氨酯保温材料有限公司 Polyhexamethylene guanide/biguanide hydrochloride immersion liquid wet tissue and the preparation method of immersion liquid

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
一种复方聚六亚甲基胍消毒剂消毒相关性能观察;曾家慧等;《中国消毒学杂志》;20200415;第37卷(第04期);第247-249页 *
几种消毒剂杀菌性能的比较试验;陈世彪;《青海大学学报(自然科学版)》;20071215;第25卷(第06期);第63-65页 *

Also Published As

Publication number Publication date
CN111671793A (en) 2020-09-18

Similar Documents

Publication Publication Date Title
JP6509948B2 (en) Antibacterial composition
EP2520605B1 (en) Method for producing biocidal polyguanidine, and biocidal polyguanidine
US8226993B2 (en) Non-toxic anti microbial composition
JP2020183396A (en) Iodophor composition with improved stability in the presence of organic material
WO2022062618A1 (en) Air filter net, production method therefor, and use thereof
CN111671793B (en) Production process of sterilized paper towel
WO2022097729A1 (en) ANTIMICROBIAL AGENT USEFUL FOR WIDE RANGE OF MICROORGANISMS INCLUDING CORONAVIRUS (FOR EXAMPLE, SARS-CoV-2)
CN113712043A (en) Graphene composite system water-based bactericidal disinfectant and preparation method thereof
Brearley et al. The rate of antimicrobial action of noxythiolin and taurolin
KR20030037094A (en) Antibiotic compositions comprising plant extract
CN104524558A (en) Enzyme compounded preparation and preparation method thereof
Bouryabaf et al. Biofilm removal and antimicrobial activities of agar hydrogel containing colloid nano-silver against Staphylococcus aureus and Salmonella typhimurium
CN111214409A (en) No-clean disinfectant and preparation method thereof
CN108605976A (en) A kind of antiseptic for inhibiting and killing germ
CN114009457B (en) Essential oil composition and application thereof
CN1301135C (en) Disposable moisture absorbent articles
CN112471174B (en) Nano-silver/domiphen bromide composite antibacterial agent and preparation method and application thereof
RU2730474C1 (en) Disinfectant composition
RU2444366C1 (en) Antibiotic resistant therapeutic biological product for bacterial and mycotic infections
CN111298108A (en) Long-acting compound enzyme disinfection composition for children and application thereof
Al-Hasnawi et al. Evaluation of Chitosan and Nano-chitosan Gel with and without 1% Silver Sulfadiazine as an Alternative for Burn Wound InfectionsTreatment in Albino Mice
CN115671344A (en) Method for sterilizing disposable sanitary articles
RU2583140C1 (en) Disinfectant
EA026955B1 (en) Disinfecting composition
CN111840273A (en) Application of chrysoeriol in preparing medicine for treating vaginitis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant